NBRx stands for New-to-Brand Prescription — a prescription for a medication the patient has never received before. NBRx, or New-to-Brand Prescription, refers to a prescription written for a medication that a patient has never previously been prescribed. This term is widely used in pharmaceutical marketing and industry analytics to track the adoption and success of new pharmaceutical products.
Quick answers: NBRx is narrower than NRx (New Prescription) — it excludes patients who have prior history with the same brand or molecule. Together with TRx (Total Prescriptions), NBRx helps pharma teams measure launch uptake and ongoing utilization.
NBRx can relate to a variety of treatment categories including chronic diseases, acute conditions, specialty drugs, and more. New diagnoses often lead to new prescriptions, making NBRx a key indicator of how often new medications are being prescribed following a specific diagnosis.
NBRx is important to healthcare because it provides valuable insights into prescribing behaviors and medication utilization. By tracking new prescriptions, healthcare analysts and pharmaceutical companies can gauge the initial acceptance and market penetration of new drugs. This information helps in evaluating the effectiveness of marketing strategies and determining the need for additional educational outreach to healthcare providers.
Moreover, understanding NBRx trends assists healthcare systems in identifying shifts in treatment approaches and patient outcomes, which can drive improvements in healthcare delivery and optimize medication management strategies. This data ultimately supports better decision-making for both healthcare professionals and patients, promoting advancements in personalized medicine and healthcare innovation.
NBRx stands for New-to-Brand Prescription. It counts prescriptions written for a medication that a patient has never previously received, making it a measure of brand adoption and new patient starts.
In pharmaceutical analytics, NBRx tracks how many patients are starting a specific brand or molecule for the first time. It is used to measure launch performance, competitive switching, and market share gains.
NRx counts any new prescription. NBRx is more specific — it only counts prescriptions where the patient has no prior history with that brand or molecule. A patient switching from a generic to a brand would generate an NRx but not an NBRx for that brand.
NBRx measures first-time brand starts only. TRx (Total Prescriptions) includes all prescriptions — both new and refills — and reflects overall drug utilization and patient adherence.